We are live on ! Find out more
Boston Partners

Boston Partners Portfolio holdings

AUM $113B
1-Year Est. Return 38.87%
This Fund
S&P 500
This Quarter Est. Return
+6.68%
1 Year Est. Return
+38.87%
3 Year Est. Return
+108.29%
5 Year Est. Return
+142.95%
10 Year Est. Return
+500.61%
AUM
$84.9B
AUM Growth
+$3.96B
Cap. Flow
-$732M
Cap. Flow %
-0.86%
Top 10 Hldgs %
17.12%
Holding
814
New
62
Increased
269
Reduced
330
Closed
71
Avg Time Held
9.5 quarters
Top 10 Avg Time Held
5.1 quarters
Top 20 Avg Time Held
6.7 quarters

Top Sells

Rank Stock Value
1
ABT icon
Abbott
ABT
+$415M
2
PHG icon
Philips
PHG
+$332M
3
TXN icon
Texas Instruments
TXN
+$300M
4
GE icon
GE Aerospace
GE
+$283M
5
DVA icon
DaVita
DVA
+$262M

Sector Composition

Rank Sector Weight
1 Financials 28.58%
2 Technology 16.65%
3 Healthcare 11.71%
4 Industrials 11.36%
5 Energy 9.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
XEC
126
DELISTED
CIMAREX ENERGY CO
XEC
$221M 0.26%
1,812,143
+395,877
+28% +$46.2M
2015 Q4
8 quarters
BDC icon
127
Belden
BDC
$4.08B
$221M 0.26%
2,861,363
+597,026
+26% +$49.3M
2013 Q2
18 quarters
CAH icon
128
Cardinal Health
CAH
$56.3B
$214M 0.25%
3,495,466
+577,099
+20% +$35.7M
2013 Q2
18 quarters
AMTD icon
129
DELISTED
TD Ameritrade Holding Corp
AMTD
$213M 0.25%
4,156,751
+1,221,924
+42% +$61.1M
2013 Q2
18 quarters
LEA icon
130
Lear
LEA
$5.82B
$209M 0.25%
1,185,890
+16,426
+1% +$2.88M
2013 Q2
18 quarters
MRSH icon
131
Marsh
MRSH
$85.1B
$204M 0.24%
2,506,998
-294,519
-11% -$24.5M
2013 Q2
18 quarters
VR
132
DELISTED
Validus Hold Ltd
VR
$201M 0.24%
4,279,398
+3,893,816
+1,010% +$192M
2013 Q2
18 quarters
PCAR icon
133
PACCAR
PCAR
$57B
$192M 0.23%
4,044,024
+809,872
+25% +$38.3M
2017 Q3
1 quarter
QRVO icon
134
DELISTED
Qorvo
QRVO
$191M 0.23%
2,869,210
+924,017
+48% +$67.3M
2015 Q4
8 quarters
GOOG icon
135
Alphabet (Google) Class C
GOOG
$4.25T
$190M 0.22%
3,624,840
-22,860
-0.6% -$1.16M
2013 Q2
18 quarters
REG icon
136
Regency Centers
REG
$13B
$187M 0.22%
2,702,234
+99,819
+4% +$6.59M
2013 Q2
18 quarters
LYG icon
137
Lloyds Banking Group
LYG
$78B
$185M 0.22%
49,446,281
-1,580,516
-3% -$5.7M
2017 Q1
3 quarters
BSX icon
138
Boston Scientific
BSX
$61.4B
$185M 0.22%
7,475,797
+276,390
+4% +$7.62M
2013 Q3
17 quarters
UHS icon
139
Universal Health Services
UHS
$10.8B
$184M 0.22%
1,620,863
+78,225
+5% +$8.36M
2016 Q2
6 quarters
UNM icon
140
Unum
UNM
$14.4B
$179M 0.21%
3,256,066
-3,214,896
-50% -$173M
2015 Q2
10 quarters
DEI icon
141
Douglas Emmett
DEI
$1.57B
$174M 0.21%
4,241,523
+159,421
+4% +$6.44M
2015 Q1
11 quarters
TSE icon
142
DELISTED
Trinseo
TSE
$169M 0.2%
+2,321,430
New +$165M
2017 Q4
0 quarters
CW icon
143
Curtiss-Wright
CW
$18.6B
$164M 0.19%
1,343,601
-17,956
-1% -$2.12M
2013 Q2
18 quarters
JAZZ icon
144
Jazz Pharmaceuticals
JAZZ
$13.9B
$161M 0.19%
+1,199,188
New +$166M
2017 Q4
0 quarters
GL icon
145
Globe Life
GL
$12.8B
$160M 0.19%
1,762,346
-122,146
-6% -$10.5M
2013 Q2
18 quarters
ETFC
146
DELISTED
E*Trade Financial Corporation
ETFC
$160M 0.19%
3,218,402
+186,549
+6% +$8.56M
2016 Q4
4 quarters
MSCC
147
DELISTED
Microsemi Corp
MSCC
$159M 0.19%
3,074,329
+73,916
+2% +$3.89M
2013 Q2
18 quarters
NFX icon
148
DELISTED
Newfield Exploration
NFX
$157M 0.19%
4,992,265
-634,772
-11% -$19.3M
2016 Q2
6 quarters
CTSH icon
149
Cognizant
CTSH
$28.3B
$157M 0.18%
2,208,803
+23,128
+1% +$1.69M
2014 Q4
12 quarters
DTE icon
150
DTE Energy
DTE
$26.6B
$156M 0.18%
+1,678,625
New +$160M
2017 Q4
0 quarters

Similar funds

Boston Partners's Q4 2017 Portfolio in Review

As of Q4 2017, Boston Partners held 814 positions worth $84.9B, up 4.9% from $80.9B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Boston Partners's Q4 2017 filing shows 62 new, 269 increased, 330 reduced and 71 closed positions. Its largest new stake was Everest Group: 1,740,653 shares worth $385M. The largest sale was Abbott, an estimated $415M.

By sector, the portfolio is most concentrated in Financials at 29% of assets, up from 28% a quarter earlier, followed by Technology and Healthcare.

  • Boston Partners's largest Q4 2017 buy was Everest Group: 1,740,653 shares worth $385M.
  • Boston Partners added most to Royal Dutch Shell PLC ADS Class A in Q4 2017, an estimated $398M increase.
  • Boston Partners's biggest Q4 2017 reduction was Abbott, cutting an estimated $415M.
  • Boston Partners fully exited Philips in Q4 2017, selling an estimated $332M.
  • Boston Partners's ten largest holdings make up 17% of its $84.9B portfolio in Q4 2017.
  • Boston Partners opened 62 new positions and closed 71 in Q4 2017.
  • Boston Partners's portfolio value rose 4.9% quarter-over-quarter to $84.9B.

Based on Boston Partners's 13F filing for Q4 2017, filed 1 Feb 2018.